ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Grants: UT Southwestern, M.D. Anderson Win Lung Cancer SPORE

December 6, 1996

DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program

September 23, 1983

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

Five Advocates Named To SWOG Committees; NCI, NASA Sign Nanotechnology Agreement.

April 21, 2000

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997